Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
Status:
Completed
Trial end date:
2019-01-19
Target enrollment:
Participant gender:
Summary
This study was designed to compare the bioavailability of the Test Product Metformin 1000 mg
Prolonged Release Tablets (JSC Farmak, Ukraine) and Reference Product Glucophage® XR 1000 mg
Prolonged Release Tablets (Merck Serono Ltd, UK) in healthy male and female volunteers under
fed conditions.